R. Rimmy Malhotra Appointed to InfuSystems Board

InfuSystem Holdings Inc. has appointed R. Rimmy Malhotra, a new independent director, to its Board of Directors. Malhotra will serve as a director until he stands for election at InfuSystem’s next Annual Shareholders meeting in May 2023.

“I have long admired InfuSystem, and believe the company has opportunity to significantly expand its business to the benefit of all stakeholders,” said Malhotra. “Managing through growth transitions is always a challenge, and this can be particularly trying for small public companies. I look forward to being part of the governance process at InfuSystem and doing my part to help the company achieve its goals.”
 
Malhotra founded The Nicoya Fund LP, a private investment partnership. He is currently a director and vice chairman of HireQuest Inc., an asset light staffing franchisor. Since November 2019, Malhotra has been a member of the Board of Directors of Optex Systems Holdings Inc., an optical systems manufacturer, and also sits on the board of Scotts Liquid Gold.

Malhotra earned an MBA in finance from The Wharton School and a master’s degree in international relations from the University of Pennsylvania where he is a Lauder Fellow. He earned undergraduate degrees in computer science and economics from Johns Hopkins University.

“We are pleased to welcome Rimmy as a new independent director on InfuSystem’s board. Rimmy first invested in the company in 2012, and has an earned reputation as a particularly attentive shareholder,” Board Chairman Scott Shuda said. “With his joining the board, the company will gain increased benefit from his perspective and insights, particularly regarding investments and capital allocation as we continue to execute on our long-term growth strategy.”
 
InfuSystem Holdings Inc. is a national healthcare service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-platform model. The lead platform is Integrated Therapy Services (ITS), providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The ITS segment is comprised of Oncology, Pain Management, Wound Therapy and Lymphedema businesses. The second platform, Durable Medical Equipment Services (DME Services), supports the ITS platform and leverages strong service orientation to win incremental business from its direct payer clients. The DME Services segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Headquartered in Rochester Hills, Mich., the company delivers local, field-based customer support and also operates Centers of Excellence in Michigan, Kansas, California, Massachusetts, Texas, and Ontario, Canada.